(Q52603038)
Statements
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin (English)
Pater JL
Carmichael JA
Krepart GV
Fraser RC
Roy M
Kirk ME
Levitt M
Brown LB
Wilson KS